| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| Piers-Grubbs第二代催化剂 | Dichloro[1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene][(tricyclohexylphosphoranyl)methylidene]ruthenium(II) tetrafluoroborate | 832146-68-6 | C40H60BCl2F4N2PRu |
| PhiKan-083盐酸盐 | 1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine | 880813-36-5 | C16H18N2 |
| Pexacerfont; 8-(6-甲氧基-2-甲基-3-吡啶基)-2,7-二甲基-N-[(1R)-1-甲基丙基]吡唑并[1,5-a]-1,3,5-三嗪-4-胺 | [14C]-Pexacerfont | 459856-18-9 | C18H24N6O |
| Paull酮 | paullone | 142273-18-5 | C16H12N2O |
| Paprotrain; (alphaZ)-alpha-(3-吡啶基亚甲基)-1H-吲哚-3-乙腈 | (Z)-2-(1H-indol-3-yl)-3-(pyridin-3-yl)acrylonitrile | 57046-73-8 | C16H11N3 |
| Palbociclib中间体 | 6-bromo-8-cyclopentyl-5-methyl-2-(methylsulfinyl)pyrido[2,3-d]pyrimidin-7(8H)-one | 571188-81-3 | C14H16BrN3O2S |
| PYRAZOLOACRIDINE无结构图 | Pyrazoloacridine methanesulfonate | 99009-21-9 | CH4O3S*C19H21N5O3 |
| PVM/MA共聚物 | vorasidenib | 1644545-52-7 | C14H13ClF6N6 |
| PTH-天冬酰胺 | D,L-asparagine N-phenylthiohydantoin | 5624-08-8 | C11H11N3O2S |
| PTH-DL-α-氨基异丁酸 | 5,5-Dimethyl-3-phenyl-2-thiohydantoin | 21083-30-7 | C11H12N2OS |
| PTH-DL-2-氨基丁酸 | 5-ethyl-3-phenyl-2-thioxoimidazolidin-4-one | 66256-32-4 | C11H12N2OS |
| PTC-209抑制剂 | PTC-209 | 315704-66-6 | C17H13Br2N5OS |
| PSS-[2-(3,4-环氧环己基)乙基]-取代七异丁基 | 1,3,5,7,9,11,13-Heptakis(2-methylpropyl)-15-[2-(7-oxabicyclo[4.1.0]heptan-3-yl)ethyl]-2,4,6,8,10,12,14,16,17,18,19,20-dodecaoxa-1,3,5,7,9,11,13,15-octasilapentacyclo[9.5.1.13,9.15,15.17,13]icosane | 445379-56-6 | C36H76O13Si8 |
| PSS-[2-(3,4-环氧树脂环己基)乙基]-七环戊基取代 | 1,3,5,7,9,11,13-heptacyclopentyl-15-[2-(7-oxabicyclo[4.1.0]heptan-3-yl)ethyl]-2,4,6,8,10,12,14,16,17,18,19,20-dodecaoxa-1,3,5,7,9,11,13,15-octasilapentacyclo[9.5.1.13,9.15,15.17,13]icosane | 307496-16-8 | C43H76O13Si8 |
| PSS-(3-缩水甘油基)丙氧基-取代七异丁基 | Pss-(3-glycidyl)propoxy-heptaisobutyl S& | 444315-17-7 | C34H74O14Si8 |
| PSN375963盐酸盐 | PSN375963 | 388575-52-8 | C17H23N3O |
| PRT-060318(PRT318)中间体 | 2-chloro-4-(3-methylanilino)pyrimidine-5-carboxylic acid | 227449-26-5 | C12H10ClN3O2 |
| PROTOPORPHYRIN營XCOBALTCHLORIDE | Co(iii) protoporphyrin ix chloride | 102601-60-5 | C34H32ClCoN4O4 |
| PROTACBET结合部分2 | (S)-4-(4-chlorophenyl)-6-(2-methoxy-2-oxoethyl)-3,9-dimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-2-carboxylic acid | 916493-82-8 | C20H17ClN4O4S |
| PPADS四钠盐 | Ppads | 149017-66-3 | C14H14N3O12PS2 |
| PORCN酶活性和WNT抑制剂(WNT-C59) | 2-(4-(2-methylpyridin-4-yl)phenyl)-N-(4-(pyridin-3-yl)phenyl)acetamide | 1243243-89-1 | C25H21N3O |
| PND-1186游离态 | 2-(2-(2-methoxy-4-morpholinophenylamino)-5-(trifluoromethyl)pyridin-4-ylamino)-N-methylbenzamide | 1061353-68-1 | C25H26F3N5O3 |
| PLK1抑制剂(RO3280) | RO3280 | 1062243-51-9 | C27H35F2N7O3 |
| PKR抑制剂,阴性对照 | 5-Chloro-3-[(3,5-dichloro-4-hydroxyphenyl)methylidene]-1,3-dihydro-2H-indol-2-one | 852547-30-9 | C15H8Cl3NO2 |
| PKR抑制剂(MITAPIVAT) | N-(4-(4-(cyclopropylmethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide | 1260075-17-9 | C24H26N4O3S |
| PKD抑制剂(CRT0066101DIHYDROCHLORIDE) | CRT0066101 Dihydrochloride | 1883545-60-5 | C18H24Cl2N6O |
| PKC抑制剂(NSC305787HYDROCHLORIDE) | NSC305787 | 53868-26-1 | C25H30Cl2N2O*ClH |
| PJ34盐酸盐 | 2-(Dimethylamino)-N-(6-oxo-5,6-dihydrophenanthridin-2-yl)acetamide hydrochloride | 344458-15-7 | C17H18ClN3O2 |
| PIM-1抑制剂2 | 4-(3-(4-chlorophenyl)benzo[c]isoxazol-5-yl)pyrimidin-2-amine | 477845-12-8 | C17H11ClN4O |
| PI3K纬INHIBITOR1 | PI3Kgamma inhibitor 1 | 1172118-03-4 | C32H26N8O2S |
| PI3K抑制剂 | 3-(4-morpholinothieno[3,2-d]pyrimidin-2-yl)phenol | 371943-05-4 | C16H15N3O2S |
| PI3K伪/MTOR-IN-1 | 2-amino-8-cyclopentyl-6-(1H-pyrazol-4-yl)-4-methylpyrido[2,3-d]pyrimidin-7(8H)-one | 1013098-90-2 | C16H18N6O |
| PI3Kα抑制剂1 | N-hydroxy-2-(methyl((2-(6-(methylamino)pyridin-3-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)amino)pyrimidine-5-carboxamide | 1235449-52-1 | C23H25N9O3S |
| PI3KΔ抑制剂(ACALISIB) | (S)-2-(1-((9H-purin-6-yl)amino)ethyl)-6-fluoro-3-phenylquinazolin-4(3H)-one | 870281-34-8 | C21H16FN7O |
| PHA-543613二盐酸盐 | PHA-543613 Dihydrochloride | 478148-58-2 | C15H19Cl2N3O2 |
| PFK158游离 | PFK158 | 1462249-75-7 | C18H11F3N2O |
| PF750;N-苯基-4-(3-喹啉基甲基)-1-哌啶甲酰胺 | N-phenyl-4-(quinolin-3-ylmethyl)piperidine-1-carboxamide | 959151-50-9 | C22H23N3O |
| PF03716556;8-[[(4R)-3,4-二氢-5-甲基-2H-1-苯并吡喃-4-基]氨基]-N-(2-羟基乙基)-N,2-二甲基咪唑并[1,2-a]吡啶-6-甲酰胺 | N-(2-hydroxyethyl)-N,2-dimethyl-8-{[(4R)-5-methyl-3,4-dihydro-2H-1-benzopyran-4-yl]amino}imidazo[1,2-a]pyridine-6-carboxamide | 928774-43-0 | C22H26N4O3 |
| PF-3758309抑制剂 | N-((1S)-2-(Dimethylamino)-1-phenylethyl)-6,6-dimethyl-3-((2-methylthieno(3,2-d)pyrimidin-4-yl)amino)-4,6-dihydropyrrolo(3,4-C)pyrazole-5(1H)-carboxamide | 898044-15-0 | C25H30N8OS |
| PF-3274167抑制剂 | (5-(3-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-5-(methoxymethyl)-4H-1,2,4-triazol-4-yl)-2-methoxypyridine) | 900510-03-4 | C19H19ClFN5O3 |
| PF-06700841甲苯磺酸盐 | brepocitinib | 1883299-62-4 | C18H21F2N7O |
| PF-04965842(阿布罗替尼) | abrocitinib | 1622902-68-4 | C14H21N5O2S |
| PF-04620110; 反式-4-[4-(4-氨基-7,8-二氢-5-氧代嘧啶并[5,4-f][1,4]氧氮杂卓-6(5H)-基)苯基]环己烷乙酸 | PF-04620110 | 1109276-89-2 | C21H24N4O4 |
| PF 8380; 4-[3-氧代-3-(2-氧代-2,3-二氢苯并恶唑-6-基)丙基]哌嗪-1-羧酸 3,5-二氯苄酯 | 3,5-dichlorobenzyl 4-(3-oxo-3-(2-oxo-2,3-dihydrobenzo[d]oxazol-6-yl)propyl)piperazine-1-carboxylate | 1144035-53-9 | C22H21Cl2N3O5 |
| PF 4942847; 2-氨基-4-[2,4-二氯-6-[2-(1H-吡唑-1-基)乙氧基]苯基]-5,7-二氢-N-(2,2,2-三氟乙基)-6H-吡咯并[3,4-d]嘧啶-6-甲酰胺 | 2-amino-4-[2,4-dichloro-6-(2-(pyrazol-1-yl)ethoxy)phenyl]-5,7-dihydropyrrolo[3,4-d]pyrimidine-6-carboxylic acid (2,2,2-trifluoroethyl)amide | 1046859-34-0 | C20H18Cl2F3N7O2 |
| PF 04217903; 2-[4-[1-(喹啉-6-甲基)-1H-[1,2,3]三唑并[4,5-b]吡嗪-6-基]-1H-吡唑-1-基]乙醇 | PF-04217903 | 956905-27-4 | C19H16N8O |
| PF 04217903 甲磺酸盐; 4-[1-(6-喹啉基甲基)-1H-1,2,3-三唑并[4,5-b]吡嗪-6-基]-1H-吡唑-1-乙醇甲磺酸盐 | PF04217903 | 956906-93-7 | CH4O3S*C19H16N8O |
| PEFICITINIB游离态 | Peficitinib | 944134-74-1 | C18H22N4O2 |
| PDK1抑制剂 | ethyl 6-(5-(phenylsulfonamido)pyridin-3-yl)imidazo[1,2-a]-pyridine-3-carboxylate | 1276110-06-5 | C21H18N4O4S |
| PD168568二盐酸盐 | PD 168568 Dihydrochloride | 210688-56-5 | C22H29Cl2N3O |